Twin Health announces revolutionary therapy for Type 2 diabetes

HYDERABAD: Twin Health, a precision health platform, recently announced its breakthrough technology, 'Whole Body Digital Twin.' The technology is approved for the remission of Type 2 diabetes and other chronic metabolic diseases like obesity, hypertension & Non-alcoholic Fatty Liver Disease (NAFLD). A total of three papers submitted to the American Diabetes Association (ADA) were selected and featured in their official press program.

The technology has been patented, and its scientific outcomes from the randomized clinical trial have been validated through acceptance in scientific sessions conducted by the American Diabetes Association (ADA), American Association of Clinical Endocrinology (AACE), International Diabetes Federation (IDF), Advanced Technologies & Treatments for Diabetes (ATTD) among other bodies.

For individuals with type 2 diabetes, remission is defined as sustaining normal blood glucose (blood sugar) levels for at least three months without taking diabetes medication.

The scientific outcomes from the Randomised Controlled Trials (RCT) and the commercial results have been published in 31 peer-reviewed international medical journals, conference papers, and abstracts. The findings were later presented as a late-breaking poster session at the 82nd Scientific Sessions of the ADA.

The study demonstrated the potential for Whole Body Digital Twin technology to help achieve remission of Type 2 diabetes without medication in the long run. The RCT demonstrated that the Whole-Body Digital Twin could empower people to reverse and prevent conditions such as diabetes, prediabetes, and obesity, as well as significantly improve diseases such as hypertension, NAFLD, etc.